Noncomplementation of radiation-induced chromosome aberrations in ataxia-telangiectasia/ataxia-telangiectasia-variant heterodikaryons.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. G2-phase radiation response in lymphoblastoid cell lines from Nijmegen breakage syndrome.Cell proliferation · 2002
   Article
2. Role of Nijmegen breakage syndrome protein in specific T-lymphocyte activation pathways.Clinical and diagnostic laboratory immunology · 2001
   Article
3. Regulation of p53 in response to DNA damage.Oncogene · 1999
   Review
4. The mammalian Mre11-Rad50-nbs1 protein complex: integration of functions in the cellular DNA-damage response.American journal of human genetics · 1999
   Review
5. Nijmegen breakage syndrome cells fail to induce the p53-mediated DNA damage response following exposure to ionizing radiation.Molecular and cellular biology · 1997
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as